主页文献库搜索
PARPis after PARPis in patients with recurrent epithelial ovarian cancer: a s...

Yuan(H),Wang(T),Yao(H),Wu(L),Li(N) J Ovarian Res 2025-09-26

...BRCA1/2 gene mutations. The median duration of PARPi1 and PARPi2 in the entire cohort was 11.2 months (range: 2.0-30.4 m...

Construction of a circRNA-miRNA-mRNA ceRNA regulatory network identifies RNAs...

Wang(W),Yang(C),Zhao(J),Cheng(X),Chen(T),Y... Arch Biochem Biophys 2025-12-00

...BRCA1, KRAS, MSH6, SMARCA4, SRC, and TSC1) exhibited significant correlations with immune infiltration (CD8+ T cells, Tr...

Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HB...

Nakamura(K),Masuda(K),Seki(T),Kitago(M),Ko... Keio J Med 2025-09-25

Hereditary breast and ovarian cancer syndrome (HBOC) is traditionally associated with mutations in the BRCA1 and BRCA2 g...

Current Situation and Future Directions of Risk-reducing Salpingo-oophorectom...

Masuda(K),Kobayashi(Y),Seki(T),Yoshihama(T... Keio J Med 2025-09-25

...BRCA1/2 pathogenic variants (PVs). The cumulative risks of ovarian cancer by the age of 70 years are 40% and 18% for car...

Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance ...

Seki(T),Kobayashi(Y),Masuda(K),Nakamura(K)... Keio J Med 2025-09-25

...BRCA1 mutations are linked to triple-negative breast cancer, whereas BRCA2 mutations typically result in luminal-type di...

Pancreatic Cancer in Hereditary Breast and Ovarian Cancer Syndrome: Is Early ...

Abe(K),Kitago(M),Kobayashi(Y),Masuda(K),Se... Keio J Med 2025-09-25

...BRCA1/2. In April 2021, our hospital established the HBOC Center, which is operated by nine departments, including obste...

Reclassification of BRCA1 and BRCA2 Variants of Unknown Significance in a Tur...

Özer(L),Aktuna(S),Ünsal(E) Eur J Breast Health 2025-09-25

...BRCA1/BRCA2 sequencing data and reclassified the BRCA1/2 variants of unknown significance (VUS) in Turkish patients with...

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ A...

Mochirian(P),Papp(R),Mathieu(MC),Ferraro(G... J Med Chem 2025-09-25

...BRCA1 or BRCA2 mutations. Here, we describe the discovery and preclinical development of RP-2119, a selective, potent, a...

[Hereditary genetic testing and its application in the diagnosis, treatment, ...

Butz(H),Patócs(A) Magy Onkol 2025-09-24

...BRCA1/2 variants, along with related screening, prevention, and management recommendations, including risk-reducing surg...

RAD51-mediated homologous recombination is a pro-tumour driver pathway.

Lopez(BS) Oncogene 2025-11-00

...BRCA1 or BRCA2) in cancer result in the absence of RAD51 on damaged DNA, leaving access to alternative exclusively mutag...

上一页 115 116 117 118 119 120 121 122 123 下一页 119 / 共 1000

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com